PL2872131T3 - Oleaceina do leczenia lub zapobiegania chorobom będących następstwem blaszki miażdżycowej - Google Patents

Oleaceina do leczenia lub zapobiegania chorobom będących następstwem blaszki miażdżycowej

Info

Publication number
PL2872131T3
PL2872131T3 PL13742600T PL13742600T PL2872131T3 PL 2872131 T3 PL2872131 T3 PL 2872131T3 PL 13742600 T PL13742600 T PL 13742600T PL 13742600 T PL13742600 T PL 13742600T PL 2872131 T3 PL2872131 T3 PL 2872131T3
Authority
PL
Poland
Prior art keywords
oleacein
treating
atherosclerotic plaques
preventing diseases
diseases resulting
Prior art date
Application number
PL13742600T
Other languages
English (en)
Inventor
Monika Ewa Czerwińska
Anna Karolina Kiss
Marek Aleksy Naruszewicz
Agnieszka FILIPEK
Original Assignee
Warszawski Univ Medyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warszawski Univ Medyczny filed Critical Warszawski Univ Medyczny
Publication of PL2872131T3 publication Critical patent/PL2872131T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/638Ligustrum, e.g. Chinese privet

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL13742600T 2012-07-14 2013-07-13 Oleaceina do leczenia lub zapobiegania chorobom będących następstwem blaszki miażdżycowej PL2872131T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL399962A PL227843B1 (pl) 2012-07-14 2012-07-14 Zastosowanie Ligustrum vulgare L. do wytwarzania preparatu zawierającego oleaceinę
PCT/EP2013/064869 WO2014012871A1 (en) 2012-07-14 2013-07-13 Oleacein for treating or preventing diseases resulting from atherosclerotic plaques
EP13742600.3A EP2872131B1 (en) 2012-07-14 2013-07-13 Oleacein for treating or preventing diseases resulting from atherosclerotic plaques

Publications (1)

Publication Number Publication Date
PL2872131T3 true PL2872131T3 (pl) 2019-05-31

Family

ID=48906224

Family Applications (2)

Application Number Title Priority Date Filing Date
PL399962A PL227843B1 (pl) 2012-07-14 2012-07-14 Zastosowanie Ligustrum vulgare L. do wytwarzania preparatu zawierającego oleaceinę
PL13742600T PL2872131T3 (pl) 2012-07-14 2013-07-13 Oleaceina do leczenia lub zapobiegania chorobom będących następstwem blaszki miażdżycowej

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL399962A PL227843B1 (pl) 2012-07-14 2012-07-14 Zastosowanie Ligustrum vulgare L. do wytwarzania preparatu zawierającego oleaceinę

Country Status (7)

Country Link
US (1) US9682056B2 (pl)
EP (1) EP2872131B1 (pl)
DK (1) DK2872131T3 (pl)
ES (1) ES2711560T3 (pl)
PL (2) PL227843B1 (pl)
PT (1) PT2872131T (pl)
WO (1) WO2014012871A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2690412B1 (es) 2017-03-10 2019-11-13 Univ Sevilla Procedimiento para la obtención de secoiridoides dialdehídicos
PL423146A1 (pl) * 2017-10-12 2019-04-23 Warszawski Univ Medyczny Oleaceina do zastosowanie w prewencji miażdżycy
GR20190100075A (el) * 2019-02-13 2020-09-16 Προκοπιος Παναγιωτη Μαγιατης Μεθοδος παραλαβης σεκοϊριδοειδων τυπου ελαιασινης και ελαιομισσιοναλης και παραγωγης των αντιστοιχων φαρμακευτικων παρασκευασματων τους
FR3147802B1 (fr) 2023-04-11 2025-11-28 Univ Montpellier Margines d’huile d’olive

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0814726B1 (pt) * 2007-07-23 2020-04-14 Euromed, S.A processo para preparar um produto nutricional e produto nutricional

Also Published As

Publication number Publication date
EP2872131A1 (en) 2015-05-20
DK2872131T3 (en) 2019-03-11
PL227843B1 (pl) 2018-01-31
PT2872131T (pt) 2019-02-26
EP2872131B1 (en) 2018-11-21
ES2711560T3 (es) 2019-05-06
WO2014012871A1 (en) 2014-01-23
US9682056B2 (en) 2017-06-20
US20160008311A1 (en) 2016-01-14
PL399962A1 (pl) 2014-01-20

Similar Documents

Publication Publication Date Title
IL272206A (en) Combined treatment for cancer
PL3967315T3 (pl) Akkermansia muciniphila do leczenia nowotworu złośliwego
IL237275A0 (en) Compounds for the treatment of paramoxovirus viral infections
GB201208088D0 (en) Ncam
IL235062A0 (en) Compounds and methods for antiviral therapy
IL263661A (en) Combination therapy for the treatment of glioblastoma
GB201217439D0 (en) Combination therapy
GB2521289B (en) Formation treatment system
GB201221123D0 (en) Device for photodynamic treatment
ZA201503005B (en) Ingenol-derived compounds useful for treating cancer
IL238415B (en) Compounds for the treatment or prevention of diseases or disorders associated with dysregulation of eif4e
IL234867A0 (en) Prevention and treatment of disease related to the tooth bearing
PL2872131T3 (pl) Oleaceina do leczenia lub zapobiegania chorobom będących następstwem blaszki miażdżycowej
PL2855475T3 (pl) Alfa-karboliny do leczenia nowotworu
DK2872176T3 (en) Cancer treatment
PL2882432T3 (pl) Sposób leczenia trądziku
EP2934500A4 (en) COMBINATION THERAPY AGAINST CANCER
GB201214877D0 (en) Compounds for treatments of tumors
IL234796B (en) Compounds for the treatment of diseases related to ischemia-reperfusion
IL236873A0 (en) therapeutic compounds
PL2692355T3 (pl) Apolaktoferyna do zastosowania w leczeniu chorób związanych z akumulacją żelaza
GB201222563D0 (en) Cancer treatment
IL239231A0 (en) Combined cancer treatment
GB201211135D0 (en) Treatment
GB201208690D0 (en) Treatment